Various types of drug-eluting stents (DES) are available in the market and has dramatically revolutionized the coronary artery disease (CAD) revascularization. This results in the decline in rates of major adverse cardiac events (MACE), and target lesion revascularization (TLR) and become a trend of revascularization in patients with CAD.
Therefore, adoption of first-generation DES such as Cyper (Johnson & Johnson Company), and Taxus (Boston Scientific) is reduced due to certain limitations such as late stent thrombosis. This lead to the introduction of next-generation drug-eluting stents offering lower restenotic rates as compared to bare metal stents (BMS) and permits more complicated lesions to be treated.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/20842
The global next generation drug eluting stent market can be segmented on the basis of polymer type, material type, end-user, and region-
Basis of polymer type
- Durable polymer
- Bioabsorbable polymer
Basis of material type
- Cobalt chromium
- Stainless steel
- Others
Basis of end user
- Hospitals
- Clinics
- Ambulatory surgical centers
Basis of region
- North america
- Latin america
- Europe
- Asia pacific
- Middle east and africa
For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/toc/20842
Since the introduction of drug-eluting stents, various technological advancement has been witnessed to generate a product offering accurate delivery of drug and safety concerns. Geographically, the global next-generation drug-eluting stent market can be segmented into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease.
In addition, the presence of sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of the next-generation drug-eluting stent market.
Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/20842
The market in the Asia-Pacific region is estimated to grow at the fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities.
Some of the market participants in the global next-generation drug-eluting stent market are Abbott Laboratories, Biosensors International Group, Ltd., Medtronic plc, Sorin Group, SMT, and Terumo Corporation.
The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com